General Information of the Compound
| Compound ID |
CP0683316
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-Hydroxy-4-(3-{4-[(10-hydroxy-14-methyl-5-oxo-5,7,8,13,13b,14-hexahydro-indolo[2',3':3,4]pyrido[2,1-b]quinazolin-3-ylamino)-methyl]-phenyl}-[1,2,4]oxadiazol-5-yl)-butyramide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C32H31N7O5
|
||||||||||||||||||
| Molecular Weight |
593.644
|
||||||||||||||||||
| Canonical SMILES |
CN1c2ccc(NCc3ccc(-c4noc(CCCC(=O)NO)n4)cc3)cc2C(=O)N2CCc3c([nH]c4ccc(O)cc34)C21
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C32H31N7O5/c1-38-26-12-9-20(33-17-18-5-7-19(8-6-18)30-35-28(44-37-30)4-2-3-27(41)36-43)15-24(26)32(42)39-14-13-22-23-16-21(40)10-11-25(23)34-29(22)31(38)39/h5-12,15-16,31,33-34,40,43H,2-4,13-14,17H2,1H3,(H,36,41)
Show/Hide
|
||||||||||||||||||
| InChIKey |
CLSJKVQAGSKSMV-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound